Filing Details
- Accession Number:
- 0001654954-17-003280
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-12 17:44:26
- Reporting Period:
- 2017-04-11
- Filing Date:
- 2017-04-12
- Accepted Time:
- 2017-04-12 17:44:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1448888 | James William Kennedy | 2 Gansevoort Street, 9Th Floor New York NY 10014 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-04-11 | 8,548 | $10.27 | 70,401 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of a total of 8,548 shares was made to satisfy Mr. Kennedy's income tax obligations from the vesting of restricted stock shares in 2016.
- Includes shares of restricted Common Stock, which vest over various time periods.
Billionaire Hedge Funds
